J B CHEMICALS AND PHARMA

Members of the Exchange are hereby informed that the trading in equity shares of JB Chemicals & Pharmaceuticals Limited shall be suspended w.e.f. July 17, 2026 (i.e., closing hours of trading on July 16, 2026) on account of the Scheme of Amalgamation.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 17-Jul-2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about General Updates

Torrent Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Change in Senior Management Personnel

JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 17, 2026. Further, the company has informed the Exchange regarding voting results.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 17, 2026

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about update on intimation dated June 12, 2026

The Exchange had sought clarification from JB Chemicals & Pharmaceuticals Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not signed by authorized signatory/ies. The response of the Company is enclosed.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Bhushan Sachdev as Other of the company w.e.f. Jun 12, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Letter to Shareholders - Integrated Annual Report 2025-26'.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding BRSR FY 26''.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Jun 17, 2026

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 29-May-2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

The Exchange has sought clarification from JB Chemicals & Pharmaceuticals Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies. The response of the Company is awaited.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement pertaining to financial results for the quarter and year ended March 31, 2026

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of Notice of hearing of Petition

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 11, 2026, recommended Final Dividend of Rs. 9.30 per equity share.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 11, 2026, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of Analyst /Investor call with Management

JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on April 28, 2026. Further, the company has informed the Exchange regarding voting results.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about proceedings of the NCLT convened meeting

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Cessation of Mr Nikhil Chopra as Chief Executive Officer of the company w.e.f. March 31, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Publication- Notice to Equity Shareholders

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026

JB Chemicals & Pharmaceuticals Limited has informed regarding Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to Scheme of Amalgamation

JB Chemicals & Pharmaceuticals Limited has informed regarding Disclosure under Regulation 30 in relation to Scheme of Amalgamation

JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.

JB Chemicals & Pharmaceuticals Limited has informed regarding Disclosure under Regulation 30

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Ms. Sushree Mishra as General Manager-Corporate Strategy, Communication and In-licensing of the Company w.e.f. March 13, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr. Jason D souza as Executive Vice President of the Company w.e.f. March 06, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr. Jason D souza as Other of the company w.e.f. March 06, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr. Kunal Khanna and Mr. Dilip Singh Rathore as Other of the company w.e.f. March 05, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper advertisement for Postal Ballot

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Postal Ballot

This is to inform you that the Compensation Committee of the Board of Directors of the Company has, on February 19, 2026, allotted 31,160 fully paid up equity shares of Re. 1/- each of the Company, to one of the ESOP holder on exercise of stock options granted to him pursuant to JBCPL Employee Stock Option Scheme, 2021

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Himanshu Ranvah as Other of the company w.e.f. February 06, 2026.